The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

Offer details
Expected size of offer (M): NIL
Expected first date of trading: 15/10/2013
Market: AIM
Location of address at which admission document will be available: Copies of the Admission Document will be made available for inspection during normal business hours on weekday (Saturdays, Sundays and public holidays will be excepted) up to the date of Admission at the Company's registered office, Lakeview House, 2 Lakeview Court, Ermine Business Park Huntingdon PE29 6UA. The Admission document will also be available at www.phytopharm.com. Following admission the Admission document will be available at www.IXICO.com
Date at which admission document will be available: -

Advisors
Sponsor: -
Nominated Advisor (AIM Companies): Peel Hunt LLP
Nominated Broker (AIM Companies): Peel Hunt LLP
Financial PR Advisors: -

Company details
Name Role
Timothy Sharpington Chief Executive Officer
Roger Hickling Research and Development Director
Alistair Henderson Taylor Non-Executive Chairman
Peter Robin Blower Non-Executive Director
Ian Frederic Tulloch Non-Executive Director

Facts and Figures
Fiscal year end: 30 September
Incorporated in: England
Website URL: www.phytopharm.com (before Admission)/ www.ixico.com (after Admission)
space
Description of business:
The Company's Investing Policy is to invest in businesses that typically have attributed to them some or all of the following characteristics: Healthcare sector; Revenue generating or near revenue generating; Embedded or protected IP; UK based; Capable of significant growth potential; and A credible management team. The Directors c...

Person(s) interested:
Invesco Asset Management 56.36% 26.15% Miton Group Plc 6.47% 3.00% Klaus Hebben 4.28% 2.02% Imperial Innovations Group plc - 11.47% Capital Number 1 Fund - 5.84% Hardsteel Limited - 5.49% Marcus Sarner - 4.19% Professor Derek Lionel Glendon Hill 0.14% 3.16%


Phytopharm plc to be renamed IXICO plc on admission

Related links

Further informations about 7 and 7/30 days issues can be find by clicking on one of the options below:

Issues last 7 days

Last issues 7/30 days

Back to New and recent issues - Home



The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds